Hims Reports Sales Shortfall Amid Rising Telehealth Competition
Hims & Hers, a leading telehealth company, reported a sales miss as competition in the digital health space intensifies. The company's financial resul...
Xeber.world
Roche
- electric vehicles
- automotive industry
- Stellantis
- collector cars
- automotive history
- Limited Edition
- classic cars
- Mecum Auctions
- supercar
- Formula 1
- Donald Trump
- AI ethics
- U.S. China relations
- AI adoption
- AI regulation
- artificial intelligence
- Trump administration
- inflation
- AI governance
- AI in business
- Bitcoin
- crypto regulation
- Senate Banking Committee
- CLARITY Act
- digital assets
- Digital Asset Market Clarity Act
- Federal Reserve
- Bitcoin price
- Bitcoin ETF
- crypto market
- AI cybersecurity
- cybersecurity
- CISA
- enterprise security
- CVE-2026-41089
- CVE-2026-41096
- Canvas data breach
- Instructure
- House Homeland Security Committee
- Donald Trump
- Netflix
- late-night TV
- Disney
- Paramount
- Cannes Film Festival
- Stephen Colbert
- Prime Video
- Jimmy Kimmel
- Marvel
- climate change
- renewable energy
- energy policy
- AI data centers
- geothermal energy
- Fervo Energy
- U.S. energy policy
- Strait of Hormuz
- Jason Bordoff
- Texas drought
- Subnautica 2
- Phasmophobia
- gaming news
- R.E.P.O.
- Forza Horizon 6
- FC 26
- Subnautica 2 tips
- Subnautica 2 guide
- Alan Wake event
- Destructoid
- FDA
- public health
- Marty Makary
- Trump administration
- healthcare policy
- Kyle Diamantas
- hantavirus
- health policy
- FDA leadership
- gene therapy
- Donald Trump
- Trump administration
- Supreme Court
- gerrymandering
- Iran war
- Voting Rights Act
- 2024 election
- Republican Party
- Virginia Supreme Court
- redistricting
- AI ethics
- climate change
- Elon Musk
- OpenAI
- ChatGPT
- tech industry
- Tesla
- remote sensing
- AI in the workplace
- generative AI
Roche Acquires PathAI in $750M Deal to Expand AI-Powered Pathology Diagnostics
Roche has agreed to acquire Boston-based PathAI for $750 million upfront, aiming to accelerate AI adoption in pathology. The deal, expected to close i...
Medicare Postpones Obesity Drug Coverage Pilot Amid Biotech Updates on RevMed, Roche, and Kyverna CAR-T Therapy
Medicare has delayed a pilot program to cover obesity drugs for seniors, reversing a key healthcare initiative from the Trump administration. This com...
Roche’s MS Drug Fenebrutinib Advances to Regulators After Positive Trial Data, But Safety Concerns Persist
Roche has presented new trial data for its experimental multiple sclerosis drug fenebrutinib, aiming to secure regulatory approval. While the drug sho...